HDR UK

What HDR UK does

Health Data Research UK (HDR UK) is a London-based non-profit organization, founded in 2017, that operates as the national coordinating infrastructure for health data research across the United Kingdom. It connects academic, clinical, and research institutions to enable large-scale, cross-institutional studies using UK patient health data, with current emphasis on neurodegenerative diseases including motor neurone disease (MND) and dementia.

HDR UK's core technology is a federated UK health data infrastructure designed to support privacy-preserving research and AI development across institutions. The Dementia Trials Accelerator (DTA), co-led with the UK Dementia Research Institute (UK DRI), links clinical survey data from the REACT cohort (12,000+ invited participants aged 65–75) to enable approved clinical trialists to identify eligible participants, with a target of 10,000+ enrolled participants by early 2027. The organization also supports international federated research networks for privacy-preserving AI development.

HDR UK's revenue model is grant-based: it is funded through UK government and charitable research grants rather than commercial product sales, with no publicly disclosed pricing. Key funding sources include the National Institute for Health and Care Research (NIHR), which awarded £2m in 2024 jointly with Dementias Platforms UK (DPUK) for an MND research initiative. Leadership includes CEO Melanie Ivarsson and Vice President Hassan Chaudhury (DATA-CAN Commercial Director). Strategic customers and collaborators are research institutions, disease foundations, and government funders rather than paying commercial clients.

Name

HDR UK

Legal name

Health Data Research UK

Website

https://hdruk.ac.uk

Company type

Private

Founded year

2017

Operating status

Operating

Headcount range

101–250 employees

Short description

HDR UK is a UK non-profit that operates national health data research infrastructure, connecting academic and clinical institutions to accelerate medical research, with current focus on dementia and motor neurone disease.

Ownership category

akta.pro rank

Product category

Health Data Research Infrastructure

NAICS

Research and Development in the Physical, Engineering, and Life Sciences (54171), Scientific Research and Development Services (5417), Computing Infrastructure Providers, Data Processing, Web Hosting, and Related Services (518)

SIC

Services-Commercial Physical & Biological Research (8731), Services-Computer Programming, Data Processing, Etc. (7370), Services-Health Services (8000)

akta.pro primary industry

Real-World Data (RWD) Platforms & Clinical Data Curation (HLACAIAJ)

akta.pro secondary industries

Decentralized/Hybrid Trial Enablement (DCT) Platforms (HLACAOAL), Real-World Data (RWD) / Real-World Evidence (RWE) & Observational Research Platforms (HLACAOAM), HIE Platforms & Network Services (Community/Regional/National) (HLACABAB), Clinical Data Repositories (CDR) & Longitudinal Patient Records (HLACAIAH)

Keywords

• Health data research
• Clinical trial acceleration
• Research data infrastructure
• Biomedical research platforms
• Health data analytics

Headquarters

HQ city

London

HQ country

United Kingdom

HQ region

Europe

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Technology or R&D, Operations, Infrastructure, Marketing or Sales

Core offering

HDR UK coordinates the UK's national health data research infrastructure, convening academic and clinical researchers to use large-scale health datasets for medical discovery. It runs flagship programs such as the Dementia Trials Accelerator, which links clinical survey and cohort data to identify eligible participants for dementia clinical trials, and joint initiatives such as the MND research program delivered with Dementias Platforms UK. Its offerings are delivered to researchers, institutions, and clinical trialists rather than sold as commercial products.

Product overview

Health Data Research UK (HDR UK) is a UK-based organization that coordinates health data research infrastructure and collaborates with partners to accelerate medical research. The sources describe initiatives such as the Dementia Trials Accelerator (DTA) and UK health data infrastructure programs, but specific product/module details and commercial offerings are not detailed in the provided source data.

Differentiator

Problem solved

Functional benefit

Products and services

• Dementia Trials Accelerator (DTA) A national program co-led by HDR UK and the UK Dementia Research Institute that links clinical survey data with cohort participant information to enable approved clinical trialists to identify eligible participants for dementia clinical trials across the UK, targeting enrollment of over 10,000 willing participants by early 2027.
• Motor Neurone Disease (MND) Research Initiative A joint HDR UK and DPUK initiative, funded with £2m from the National Institute for Health and Care Research, that uses UK health data infrastructure to accelerate motor neurone disease research, supporting improved diagnostics, treatments, and care for MND patients.

Quantifiable outcome

• Reduces dementia clinical trial duration from 4.5 years (current average) toward 2.3 years (average cancer trial benchmark)
• +1 more outcomes

Segments1 record

Ideal customer profiles2 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Partnerships

Three partnerships are on record, tiered core.

• UK Dementia Research Institute (UK DRI)coreStrategic or Co-development Partner · 8 April 2026Joint leadership of the Dementia Trials Accelerator (DTA), an initiative to address chronic under-recruitment in dementia clinical trials. UK DRI and HDR UK are co-leading this platform which will link gathered clinical information to survey data, enabling approved clinical trialists to identify eligible participants across the UK.
• Dementias Platforms UK (DPUK)coreStrategic or Co-development Partner · 30 July 2024HDR UK and DPUK received £2m in funding to create a new initiative aimed at accelerating motor neurone disease (MND) research in the UK. The initiative will utilize UK health data infrastructure and foster collaborations to improve diagnostics, treatments, and care for MND patients.
• REACT Cohort Study ParticipantscoreOthersOver 12,000 participants aged 65-75 from the REACT cohort study have been invited to initial clinics as part of the Dementia Trials Accelerator initiative, with a target of enrolling over 10,000 willing participants by early 2027.

Scale indicators3 records

Recent moves5 records

Expansion highlights5 records

Direct peers

• Dementias Platforms UK (DPUK): UK-based data infrastructure consortium focused specifically on dementia research. DPUK is a direct co-partner with HDR UK on the £2m MND research initiative and shares the same national infrastructure model for neurodegenerative disease research.
• UK Dementia Research Institute (UK DRI): The UK's leading dementia research institute and co-leader of the Dementia Trials Accelerator with HDR UK. UK DRI brings the basic and translational science capability that complements HDR UK's data infrastructure, making them a tightly coupled peer/partner.
• UK Biobank: Large-scale UK biomedical database with deep phenotypic and genomic data on 500,000+ participants. UK Biobank is the closest analog to HDR UK's federated infrastructure model and competes for the same research-sponsor and academic data-access relationships.
• Genomics England: UK government-backed organization providing genomic data infrastructure for research and clinical care. Genomics England is structurally similar to HDR UK — a national, publicly-funded health data platform — and operates in adjacent data domains.
• Observational Health Data Sciences and Informatics (OHDSI): International multi-stakeholder collaborative that builds and applies observational research methods to large-scale health data. OHDSI's federated network model overlaps directly with HDR UK's federated AI/analytics infrastructure approach.

Broad incumbents

• National Institutes of Health (NIH) — All of Us Research Program: US national precision-medicine initiative building a massive health data resource from one million+ participants. Comparable in mission to HDR UK but operating at much larger scale and budget as a federal program; serves as a model and competitor for international sponsors.
• European Health Data Space (EHDS): EU-level initiative to enable cross-border health data access for research and care. EHDS represents both a peer (federated health data infrastructure) and a potential competitor that could subsume or interoperate with HDR UK's UK-centric model.
• Sentinel Initiative (US FDA): US FDA's national electronic health data system for monitoring the safety of regulated medical products. Sentinel is a public-sector health data platform with a regulatory mandate, comparable in role and scale to HDR UK but oriented toward drug safety rather than general research.

Regional players

• Health Data Research Network Canada: Canadian multi-provincial health data research network with a similar federated, multi-institutional structure. Operates in a different geography but follows the same national-research-infrastructure playbook as HDR UK.
• Findata (Finnish Social and Health Data Permit Authority): Finnish national authority enabling secondary use of health and social data for research. Comparable in operating model — a national body facilitating health data access — but serves Finland specifically rather than competing in the UK market.

Market position

Strengths4 records

Weaknesses3 records

Competitive moat4 records

Key risks6 records

Key highlights6 records

Customer concentration

• Xx.com/hdr_uk

Revenue estimate

Valuation estimate

Number of profiles

Profiles2 records

Funding overview

Funding rounds1 record

Investors1 record

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about HDR UK